This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aic246 Ag & Co. Kg. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Monica Rosa and Her Pharmaceutical Patent
Introduction
Monica Rosa is an inventor associated with Munich, Germany. Her patent work concerns a pharmaceutical composition designed to support stability and potential antiviral use.
Latest Patents
Rosa is named on 1 patent, titled “Pharmaceutical compositions comprising 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate and sodium ions.” The invention describes stable pharmaceutical compositions containing the specified compound and sodium ions, formulated essentially without complexing solubilizing agents such as polyethylene glycol, cyclodextrin, lysine, or arginine, particularly HPBCD. It also covers preparation methods and potential use in treating or preventing illnesses, including antiviral applications, preferably against cytomegaloviruses.
Career Highlights
Rosa is associated with Aic246 AG & Co. KG. The available information identifies her contribution through this pharmaceutical patent and does not provide further details about her professional history.
Collaborations
The patent’s listed collaborators include Dorothea Hohmann and Thomas Goldner.
Conclusion
Monica Rosa’s documented invention focuses on a stable pharmaceutical composition and its preparation, with proposed applications that include antiviral treatment and prevention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile